Omada Health, Inc.
Company Information
Industry Services-Health Services
SIC Code 8000
Entity Type operating
SEC Category Non-accelerated filerEmerging growth company
State of Incorporation DE
Business Address 611 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080
Mailing Address 2202 S. COCKRELL HILL ROAD, DALLAS, TX, 75211
Phone 888-987-8337
Fiscal Year End 1231
EIN 452355015
Financial Overview
FY2025
$229.68M
Stockholders' Equity
$-6.11
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 11, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 10-K Annual financial report | March 6, 2026 | View on SEC |
Annual Reports
10-K March 6, 2026
- Completed IPO on June 9, 2025, raising $150 million in net proceeds to fuel growth.
- Achieved significant revenue growth of 35% to $285 million in 2025, driven by increased program adoption.
Insider Trading
STRONG SELL 3 insiders
9 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8000)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.